Literature DB >> 8867021

Apolipoprotein E polymorphism in patients with different neurodegenerative disorders.

S Helisalmi1, K Linnaranta, M Lehtovirta, A Mannermaa, O Heinonen, M Ryynänen, P Riekkinen, H Soininen.   

Abstract

Apolipoprotein E (ApoE) is associated with Alzheimer's disease (AD) neurofibrillary tangles and beta-amyloid protein in senile plaques. There are three common alleles of ApoE, designated epsilon 2, epsilon 3 and epsilon 4. We studied Finnish patients with neurodegenerative disorders: AD, vascular dementia (VAD), Parkinson's disease (PD), PD+dementia (PDD), Lewy body variant of AD (LB), frontal dementia (FD), and Down's syndrome (DS), as well as control individuals (C). The ApoE genotypes and corresponding allele frequencies of 188 patients and 60 controls were determined by digestion of ApoE polymerase chain reaction products with the restriction enzyme Hha I. The ApoE epsilon 4 allele frequency was 0.17 for C, 0.44 for AD, 0.35 for VAD, 0.10 for PD, 0.38 for PDD, 0.28 for LB, 0.39 for FD, and 0.17 for DS. We found significant differences in genotype frequency between AD/C, AD/PD and AD/DS. Our results suggest that, beside AD, an increased frequency of epsilon 4 may also be involved in other dementing neurological disorders.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8867021     DOI: 10.1016/0304-3940(96)12373-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  14 in total

1.  Unilateral a(1) and m(1) occlusions in a child with trisomy 21.

Authors:  P Corr; P Lasjaunias
Journal:  Interv Neuroradiol       Date:  2001-10-15       Impact factor: 1.610

Review 2.  Frontotemporal lobar degeneration: current knowledge and future challenges.

Authors:  Chiara Cerami; Elio Scarpini; Stefano F Cappa; Daniela Galimberti
Journal:  J Neurol       Date:  2012-04-25       Impact factor: 4.849

3.  Apolipoprotein Ε ε4 frequency is increased among Chinese patients with frontotemporal dementia and Alzheimer's disease.

Authors:  Yong Ji; Mengyuan Liu; Ya Ruth Huo; Shuling Liu; Zhihong Shi; Shuai Liu; Thomas Wisniewski; Jinhuan Wang
Journal:  Dement Geriatr Cogn Disord       Date:  2013-07-23       Impact factor: 2.959

Review 4.  Is apolipoprotein E4 an important risk factor for vascular dementia?

Authors:  Troy T Rohn
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

Review 5.  Transcriptional Effects of ApoE4: Relevance to Alzheimer's Disease.

Authors:  Veena Theendakara; Clare A Peters-Libeu; Dale E Bredesen; Rammohan V Rao
Journal:  Mol Neurobiol       Date:  2017-09-06       Impact factor: 5.590

6.  The apolipoprotein E epsilon4 allele selectively increases the risk of frontotemporal lobar degeneration in males.

Authors:  R Srinivasan; Y Davidson; L Gibbons; A Payton; A M T Richardson; A Varma; C Julien; C Stopford; J Thompson; M A Horan; N Pendleton; S M Pickering-Brown; D Neary; J S Snowden; D M A Mann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

7.  Neuronal apoptosis by apolipoprotein E4 through low-density lipoprotein receptor-related protein and heterotrimeric GTPases.

Authors:  Y Hashimoto; H Jiang; T Niikura; Y Ito; A Hagiwara; K Umezawa; Y Abe; Y Murayama; I Nishimoto
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

8.  Genetics and biology of Alzheimer's disease and frontotemporal lobar degeneration.

Authors:  Daniela Galimberti; Elio Scarpini
Journal:  Int J Clin Exp Med       Date:  2010-05-15

9.  Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.

Authors:  Ging-Yuek R Hsiung; A Dessa Sadovnick; Howard Feldman
Journal:  CMAJ       Date:  2004-10-12       Impact factor: 8.262

10.  Genetics of frontotemporal lobar degeneration.

Authors:  Daniela Galimberti; Elio Scarpini
Journal:  Front Neurol       Date:  2012-04-10       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.